Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
24th April 25. Perusing thru last few years metrics of revenue, profit margin abt 12%, earnings, dividends, dv policy of 30%, dv yield, debt abt 933m, 252m cash as in mid 2024, expect earnings & dividends to be cut in 2025.
At RM3.38 it's grossly overpriced.. Even sustaining 12c dividend, price should be RM2.40-2.70 based on dv yield.
Don't get screwed by high priced tickets. It's time shareholders get reasonable priced shares with good dv yield at below RM3.
Those who got screwed above RM4.50 please go AGM and demand for higher dv payout ha ha
For those new investors, Scientx is not a great Co. with outstanding awesome metrics, as one would think. It's just another average property Co and plastic film producer struggling to gain market shares in an ever challenging biz environment.
Take your money to where it is treated best. Good luck guys
If property earnings is good thus the next quarter should pose a better result n ultimately the yearly profit shall be more likewise the dividend payout shall increase in tandem
You've been calling to buy Scientx last year when price was RM4.5++ ha ha
Why don't you analyse the metrics of Scientx instead of copying from AI dumbo, ha ha
If PJ have to come in to prop up the price, that should tell you something is very wrong with this stock. Ha ha, it's still overpriced at 337c.
Earnings to drop further ha ha
As of April 21, 2025, Scientex Berhad (KLSE: SCIENTX) is trading at RM3.43. Analysts have a positive outlook, with an average 12-month target price of RM4.08, suggesting a potential upside of approximately 19% from the current price .  
Short-Term Outlook:
Short-term forecasts indicate a potential decline in the coming week. Projections suggest the stock could decrease to around RM3.33, with a possible low of RM3.20 . 
Key Considerations:
• Recent Performance: The stock has declined by approximately 13.6% over the past year .
• Valuation: Currently trading at a price-to-earnings (P/E) ratio of 10.14, which is considered reasonable .
• Dividend Yield: Offers a forward annual dividend yield of 3.54% .
• Volatility: With a beta of 0.34, the stock exhibits lower volatility compared to the broader market .   
Conclusion:
While the short-term outlook suggests a potential decline, the medium to long-term prospects appear favorable based on analyst consensus and valuation metrics. Investors should consider their risk tolerance and investment horizon when making decisions.
As of April 18, 2025, Scientex Berhad (KLSE: SCIENTX) is experiencing a short-term bearish trend. Technical indicators from TradingView signal a “strong sell” for the upcoming week, with a one-month outlook also leaning towards a “sell” recommendation. 
Recent technical metrics highlight this downward momentum:
• MACD (26 vs 12): -0.113
• 5-day EMA: RM3.33
• 20-day EMA: RM3.47
• 90-day EMA: RM3.87
• Relative Strength Index (14): 36, indicating the stock is approaching oversold territory.   
Despite the current technical indicators, some analysts view Scientex as undervalued in the long term. A recent analysis estimates its fair value at RM6.30, suggesting a potential upside of approximately 47% from its current price of RM3.33. 
In summary, while short-term technical signals point to a bearish trend, long-term fundamentals may offer a more optimistic outlook. Investors should consider both perspectives when making decisions.
Analyst call of TP RM6.30 is ludicrous and dumbest thing I've heard all month, ha ha In the best of years, it could not even cross the RM5 mark. With rising cost of construction & production and intense competition, it no longer has the competitive edge it used to have.
As of April 18, 2025, Scientex Berhad (KLSE: SCIENTX) is trading at RM3.40, just above its 52-week low of RM3.21. Analysts are offering mixed short-term forecasts for the stock. 
Short-Term Forecast (Next Week):
• WalletInvestor predicts a modest upward trend, estimating the stock price to reach RM3.61 within the next 14 days. 
• TradingView provides a 12-month average price target of RM4.08, with estimates ranging from RM3.60 to RM5.54. 
• RHB Research has revised its target price to RM3.70, maintaining a neutral outlook. 
Market Sentiment:
Despite a recent dip in earnings per share (EPS) to RM0.08 in Q2 FY2025, analysts anticipate an annual EPS growth of 8.6%. The stock is currently trading at a price-to-earnings (P/E) ratio of 10.1, aligning with its historical average, suggesting a fair valuation.  
Given the current market conditions, Scientex’s stock may experience modest fluctuations in the coming week. Investors should monitor upcoming earnings reports and market news to make informed decisions. 
